pharmaceutical investing Concert Pharmaceuticals Initiates Phase 1 Multiple-Ascending Dose Trial of CTP-692
Goldgroup Announces Nominees to Board in Connection with Proposed Business Combination with Gold Resource Corporation and Amends Arrangement Agreement